Home Cavion

Cavion

acquired
Series A
Disease Treatment Drug Developer
Basic
Enterprise Profile

Basic Information

Cavion is a clinical-stage pharmaceutical company dedicated to providing treatments for cancer and neurological disorders by developing drugs that selectively inhibit T-type calcium channels (Cav3).
Cavion, Inc.
Virginia,United States of America
15~50 people
January 01, 2003
info@cavionpharma.com

Enterprise Profile

Industrial Sector
Drug Trial
Concept
Tumor # Nervous System Diseases Therapeutic Products
Application Scenarios
Innovative Drugs